UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 17, 2017
Cross Country Healthcare, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 0-33169 | 13-4066229 |
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
5201 Congress Avenue, Boca Raton, FL 33487
(Address of Principal Executive Office) (Zip Code)
(561) 998-2232
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Information
On March 17, 2017, Cross Country Healthcare, Inc. (the “Company”) repaid in full its convertible senior notes (the “Convertible Notes”). The Convertible Notes, with an aggregate principal amount of $25,000,000, were convertible into shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a conversion price of $7.10 per share. In connection with the repayment, the Company issued to the holders of the Convertible Notes an aggregate of 3,175,584 shares of Common Stock and cash in the aggregate amount of $5,988,889, including all remaining interest payments through the optional conversion date of June 30, 2017.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| | | CROSS COUNTRY HEALTHCARE, INC. |
| | | | |
| | | | |
| | | By: | /s/ William J. Burns |
| | | | William J. Burns |
| Dated: | March 17, 2017 | | EVP, Chief Financial Officer |
